Available Trials

Hematologic

  • USOR 16092

    Prospective, Longitudinal, Non-Interventional, Study of Disease Burden and Treatment of Patients with Low-Risk Myelofibrosis (MF) or High-Risk Essential Thrombocytemia (ET) or ET Patients Recieving ET-Directed Therapy (MOST)

    Available at 7 locations

  • MDS/AML OBSERVATIONAL STUDY

    Connect MDS and AML Disease registry

    Available at 6 locations